Dimerix (ASX:DXB) Share Price and News - StockTrack

Market Cap (19-Sep) $102,067,456 (1,050th)	Close (30-Jun) $0.062 0 (0%)	Volume (30-Jun) 526,676	Shortsold (26-May) 683,172 (0.11%) (444th)
52w High $0.67	52w Low $0.165	P/E 10.78	EPS -0.03

	Subject
	DXB DXB Ann: Notification regarding unquoted securities - DXB
	1 (current) 2 3
	DXB DXB Ann: Notification regarding unquoted securities - DXB
	DXB DXB Ann: Notification regarding unquoted securities - DXB
	DXB DXB Ann: Application for quotation of securities - DXB
	DXB DXB Ann: Application for quotation of securities - DXB
	DXB DXB Ann: Dimerix Closes SPP Oversubscribed
	DXB DXB Ann: Results of Meeting
	DXB DXB Ann: AGM Presentation
	DXB DXB Ann: CEO's Address to Shareholders
	DXB DXB Ann: Virtual Meeting Voting and Registration Guide
	DXB DXB Ann: DMX-200 CLARITY COVID-19 Study Approval in India
	DXB DXB Ann: Change of Director's Interest Notices - JW, HA and SP
	DXB DXB Ann: Change in substantial holding
	DXB DXB Ann: Phase 3 Study in FSGS Kidney Patients Commences
	DXB DXB Ann: Notice of Annual General Meeting/Proxy Form
	DXB DXB Ann: Annual General Meeting - Notice and Letter to Shareholders
	DXB DXB Ann: SPP and Options Prospectus
	DXB DXB Ann: Secondary Trading Notice Pursuant to Section 708A(5)(e)
	DXB DXB Ann: Application for quotation of securities - DXB
	DXB DXB Ann: Application for quotation of securities - DXB
	DXB DXB Ann: Response to ASX Query
	DXB DXB Ann: Secondary Trading Notice Pursuant to Section 708A(5)(e)
	DXB DXB Ann: Application for quotation of securities - DXB
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Appendix 4G and Corporate Governance Statement
	DXB DXB Ann: Annual Report to Shareholders
	DXB DXB Ann: Preliminary Final Report
	DXB DXB Ann: Proposed issue of securities - DXB
	DXB DXB Ann: Proposed issue of securities - DXB
	DXB DXB Ann: Proposed issue of securities - DXB
	DXB DXB Ann: Proposed issue of securities - DXB
	DXB DXB Ann: Successful $20m Placement to Fund Phase 3 Trials
	DXB DXB Ann: Trading Halt
	DXB DXB Ann: DMX-200 COVID-19 Study Opens More Sites in Europe and UK
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: FDA Confirms Phase 3 Study Design in FSGS Kidney Disease
	DXB DXB Ann: Dimerix Receives Innovation Passport and ILAP Designation
	DXB DXB Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA
	DXB DXB Ann: DMX-200 Remains Eligible for Accelerated Approval
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Update of DMX-200 Study in COVID-19 Patients in India
	DXB DXB Ann: COVID-19 Study Recruits Multiple Patients in Europe
	DXB DXB Ann: Notification of Expired Options
	DXB DXB Ann: Quarterly Appendix 4C and Activities Report
	DXB DXB Ann: Major Shareholder Loan for $5 Million
	DXB DXB Ann: Investor Presentation
	DXB DXB Ann: Clinical Study in Patients with COVID-19 Progresses
	DXB DXB Ann: DMX-200 Competitive Position Further Enhanced
	DXB DXB Ann: Lapse of Unlisted Options
	DXB DXB Ann: CLARITY 2.0 Study Progresses In Patients With COVID-19

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.54	1,071,324	+0.02 (3.88%)
12-Sep	$0.52	2,727,613	+0.05 (9.57%)
11-Sep	$0.47	1,085,191	+0.00 (1.08%)
05-Sep	$0.47	1,002,355	-0.02 (3.12%)
04-Sep	$0.48	2,097,380	+0.02 (3.23%)
03-Sep	$0.47	1,316,388	+0.02 (3.33%)
29-Aug	$0.45	1,599,553	+0.01 (1.12%)
28-Aug	$0.45	1,965,034	-0.01 (2.20%)
22-Aug	$0.46	1,500,535	-0.01 (2.15%)
21-Aug	$0.47	693,374	0.00 (1.06%)
15-Aug	$0.47	1,419,813	0.00 (0.00%)
14-Aug	$0.47	1,532,339	-0.04 (7.84%)
07-Aug	$0.51	1,747,131	+0.04 (8.51%)
31-Jul	$0.47	2,509,167	-0.01 (1.05%)
30-Jul	$0.48	3,440,497	-0.04 (6.86%)
7 up, 7 down, and 1 flat days

High $0.06	Low $0.06	Trades 18	Turnover $32,113	Volume 526,676
30 June 2023 at 3:59pm

High $0.06	Low $0.06	Trades 18	Turnover $32,113	Volume 526,676
30 June 2023 at 3:59pm

Dimerix Health Care

$0.062 0.002 (3.33%)

$0.062 0.002 (3.33%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices